M
Mindera Health
MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases
About Mindera Health
Mindera Health operates in the healthcare technology sector, focusing on dermatology and precision medicine. The company leverages advanced technology to generate clinically validated data aimed at reducing healthcare costs and improving patient outcomes. Their core product, a minimally invasive patch, captures thousands of RNA transcripts in just five minutes, enabling scalable collection and analysis of individualized genetic information. This data is used to provide actionable, data-driven decisions for patients, healthcare providers, and payers. Mindera Health's flagship test, Mind.Px, uses artificial intelligence and deep learning to identify biomarkers and predict patient responses to expensive psoriasis biologic drugs. This allows for more precise treatment selection, improving the management of psoriasis and significantly reducing healthcare costs. The company primarily serves dermatologists, healthcare providers, and insurance payers, operating in the precision medicine and dermatology markets. Mindera Health's business model revolves around selling their diagnostic tests and data analytics services, generating revenue through direct sales and partnerships with healthcare providers and payers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Vista, United States
- Employees
- 22
- Open positions
- 1
- Dealroom signal
- 60.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Oncology, Non-Invasive medical devices and treatments, Spinout, Biotech and Pharma, medical testing, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2026 | $0 | — | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Jul 2026 | $30M | $122M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Mindera Health is 2.6K monthly website visits, up 73.3% over the last three months. Mindera Health's team declined 4.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Scientific Health Development Partners
Andrew Offer
Series A1 investor entered at this stage
Rockmont Partners
Series B and later2 investors entered at this stage
- PCPrimer Capital
Mountain Group Partners
Other known investors2 additional known investors
Scripps Translational Science Institute
Grant Park Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mindera Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mindera Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.